Red flags to suspect inborn errors of immunity in patients with autoimmune diseases; [Señales de alerta para sospechar de errores innatos de la inmunidad en pacientes con enfermedades autoimmunitarias]
Autores organización
Autores
- Vélez N.
- Cortés J.
- Barrero N.
- Rojas L.
- Bello J.M.
Unidades de investigación
Resumen
Inborn errors of immunity are monogenic disorders that predispose patients to immune dysregulation, autoimmunity, and infection. Some autoimmune diseases, such as autoimmune cytopenias, systemic lupus erythematosus, and inflammatory bowel diseases, are increasingly recognized as phenotypes of inborn errors of immunity. The objective of this article was to identify red flags or clinical/laboratory markers to suspect inborn errors of immunity in patients with autoimmune cytopenias, systemic lupus erythematosus, and inflammatory bowel diseases through a systematic literature review. The study followed the systematic reviews and meta-analysis guidelines (PRISMA). After selection, we included 36 articles, and their methodological quality was verified using the Joanna Briggs Institute tools for individual risk of bias analysis. The principal red flags in autoimmune cytopenias are chronic, recurrent, and refractory cytopenias, recurrent infection, severe infectious complications associated with immunosuppressive treatment, and chronic lymphoproliferation. In systemic lupus erythematosus, red flags include age of onset before five years, severe organ involvement, chilblain lesions, and chronic lymphoproliferation. For inflammatory bowel diseases, red flags are an age of onset before two years, resistance to conventional therapies, atypical endoscopic or histologic findings, and consanguineous parents. Autoimmune diseases may be the primary manifestation of inborn errors of immunity in pediatric and adult patients. An early diagnosis of a monogenic disorder allows for the tailoring of effective treatment plans, providing prognostic information to families, and offering genetic counseling. © (2024), (Instituto Nacional de Salud). All rights reserved.
Datos de la publicación
- ISSN/ISSNe:
- 0120-4157, 2590-7379
- Tipo:
- Article
- Páginas:
- 236-262
- PubMed:
- 39836840
- Enlace a otro recurso:
- www.scopus.com
Biomedica Instituto Nacional de Salud
Documentos
- No hay documentos
Filiaciones
Filiaciones no disponibles
Keywords
- anemia hemolítica autoinmunitaria; anemia, hemolytic, autoimmune; autoimmune diseases; Autoimmunity; autoinmunidad; citopenia; cytopenia; early-onset immune dysregulation; enfermedades autoinmunitarias; enfermedades inflamatorias intestinales; inflammatory bowel disease; lupus eritematoso sistémico; lupus erythematosus, systemic; thrombocytopenia; trombocitopenia;Autoimmune Diseases; Humans; Inflammatory Bowel Diseases; Lupus Erythematosus, Systemic; autoimmune disease; diagnosis; human; immunology; inflammatory bowel disease; systemic lupus erythematosus
Proyectos asociados
Desarrollo de un modelo de Machine Learning para la prevención de infección de vías urinarias y enfermedad diarreica aguda en pacientes con trasplante renal
Investigador Principal: CARLOS ALBERTO PUENTES MORALES
PCI-2023-0010 . 2023
Desarrollo de un genosensor para la identificación de Helicobacter pylori en fluidos fisiológicos
Investigador Principal: SANDRA JANNETH PERDOMO LARA
PCI-2023-0020 . 2023
Evaluación de la Inmunidad inducida por las Vacunas anti-SARS-CoV-2 frente a las variantes B.1.617.2 (Delta) y P.1 (Gamma) en individuos residentes de Bogotá
Investigador Principal: MIGUEL HERNANDO PARRA AVILA
UEB-2021-644 . 2022
DESARROLLO DE UNA PLATAFORMA WEB PARA EL DIAGNÓSTICO TEMPRANO DE CÁNCER CERVICAL EN PACIENTES DE LA CIUDAD DE BOGOTÁ ASISTIDO POR INTELIGENCIA ARTIFICIAL
Investigador Principal: SANDRA JANNETH PERDOMO LARA
UEB-2022-673 . 2023
Citar la publicación
Vélez N,DE AVILA J,Cortés J,Barrero N,Rojas L,Bello JM,ROMERO MC. Red flags to suspect inborn errors of immunity in patients with autoimmune diseases; [Señales de alerta para sospechar de errores innatos de la inmunidad en pacientes con enfermedades autoimmunitarias]. Biomedica. 2024. 44. p. 236-262. IF:0,800. (4).
Portal de investigación